Aeterna Zentaris to Present at Oppenheimer 23rd Annual Healthcare Conference in New York

About this update from Cosciens Biopharma Inc.

[{"type":"text","content":"\n\n\n\n\n\nQUÉBEC CITY, Dec. 4, 2012 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ:\n AEZS) (TSX: AEZ) (the \"Company\") today announced that its Senior Vice\n President and Chief Medical Officer, Paul Blake, MD, will be presenting\n a corporate overview at the Oppenheimer 23rd Annual Healthcare Conference on Thursday, December 13, 2012, at 9:25 am\n (Eastern), in the East Foyer of The Waldorf-Astoria Hotel in New York\n City.\n\n\nA live webcast of this presentation will be available on Aeterna\n Zentaris' website at www.aezsinc.com, in the \"Newsroom\" section. A replay of the webcast will also be\n available on the Company's website for a period of 90 days.\n\n\nAbout Aeterna Zentaris \n\n\nAeterna Zentaris is an oncology and endocrinology drug development\n company currently investigating treatments for various unmet medical\n needs. The Company's pipeline encompasses compounds at all stages of\n development, from drug discovery through to marketed products. For more\n information please visit www.aezsinc.com.\nSOURCE: AETERNA ZENTARIS INC.\n\n\n Investor Relations Ginette Beaudet Vallières Investor Relations Coordinator (418) 652-8525 ext. [email protected] Media Relations Paul Burroughs Director of Communications (418) 652-8525 ext. [email protected] \n","length":1622,"tagName":"div"}]

More updates from Cosciens Biopharma Inc.